Lataa...
Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature
BACKGROUND: Use of immune checkpoint inhibitors in treatment of gynecologic malignancies is increasing. Rare, but potentially fatal, immune-related neurologic adverse events may occur as a result of treatment. CASE: A 72 year old female with recurrent metastatic uterine adenocarcinoma received pembr...
Tallennettuna:
| Julkaisussa: | Gynecol Oncol Rep |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967007/ https://ncbi.nlm.nih.gov/pubmed/33748382 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2021.100739 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|